Cargando…

Molecular target therapy – towards curative regimen: a 20-year experience in the treatment of acute promyelocytic leukemia (APL) in the Shanghai Institute of Hematology

Detalles Bibliográficos
Autor principal:	Shen, Zhi-Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322486/ https://www.ncbi.nlm.nih.gov/pubmed/19558731 http://dx.doi.org/10.1186/1756-8722-2-S1-A1

Ejemplares similares

Acute promyelocytic leukemia (APL): a review of the literature
por: Jimenez, Joaquin J., et al.
Publicado: (2020)

Acute Promyelocytic Leukemia (APL): Comparison Between Children and Adults
por: Testi, Anna Maria, et al.
Publicado: (2014)

Charting a course through the acute promyelocytic leukemia (APL)-like nebula: the enigmatic cousins of APL
por: Ghiaur, Alexandra, et al.
Publicado: (2023)

Acute promyelocytic leukemia presenting as pulmonary thromboembolism: Not all APLs bleed
por: Vaid, Ashok K, et al.
Publicado: (2015)

Secondary clonal hematologic neoplasia following successful therapy for acute promyelocytic leukemia (APL): A report of two cases and review of the literature
por: Gaut, Daria, et al.
Publicado: (2018)

Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group
por: Adès, Lionel, et al.
Publicado: (2018)

Distribution of Different PML/RARα bcr Isoforms in Indian Acute Promyelocytic Leukemia (APL) Patients and Clinicohematological Correlation
por: Chatterjee, Tathagata, et al.
Publicado: (2014)

Regulation of cell surface protease receptor S100A10 by retinoic acid therapy in acute promyelocytic leukemia (APL)(☆)
por: Holloway, Ryan W., et al.
Publicado: (2018)

Incidence of the 15q+;17q- chromosome translocation in acute promyelocytic leukaemia (APL).
por: Sheer, D., et al.
Publicado: (1985)

UK Experience of an Alternative ATO Dosing Regimen in APL
por: Russell, Nigel, et al.
Publicado: (2020)

Arsenic Combined With All-Trans Retinoic Acid for Pediatric Acute Promyelocytic Leukemia: Report From the CCLG-APL2016 Protocol Study
por: Zheng, Huyong, et al.
Publicado: (2021)

Evolving Chemotherapy Free Regimens for Acute Promyelocytic Leukemia
por: Kulkarni, Uday, et al.
Publicado: (2021)

Differentiation Syndrome in Acute Leukemia: APL and Beyond
por: Woods, Ashley C., et al.
Publicado: (2023)

Multicenter randomized trial of arsenic trioxide and Realgar‐Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG‐APL clinical study
por: Yang, Ming‐Hua, et al.
Publicado: (2018)

Cost-effectiveness of the regimen proposed by the International Consortium on Acute Promyelocytic Leukemia for the treatment of newly diagnosed patients with Acute Promyelocytic Leukemia
por: Rodríguez-Rodríguez, Sergio, et al.
Publicado: (2021)

Case Report: Very Late, Atypical Extra-Medullary Relapse in a Patient With Acute Promyelocytic Leukemia (APL) Rescued With a Transplant-Free Approach
por: Molica, Matteo, et al.
Publicado: (2021)

An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial)
por: Wang, Huai-Yu, et al.
Publicado: (2022)

S136: ANALYSIS OF FACTORS ASSOCIATED WITH LONG-TERM SURVIVAL IN A LARGE ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENT COHORT: A HARMONY ALLIANCE STUDY
por: Guarnera, Luca, et al.
Publicado: (2023)

APL Congress
por: Gjerløv, Per, et al.
Publicado: (1973)

APL : a short course
por: Pakin, Sandra
Publicado: (1973)

APL2 in depth
por: Thomson, Norman D, et al.
Publicado: (1995)

APL 76 Conference
por: Hunter, G Truman
Publicado: (1976)

International Conference on APL
por: Van der Linden, Gijsbert
Publicado: (1980)

Impact of CD56 Continuously Recognizable as Prognostic Value of Acute Promyelocytic Leukemia: Results of Multivariate Analyses in the Japan Adult Leukemia Study Group (JALSG)-APL204 Study and a Review of the Literature
por: Takeshita, Akihiro, et al.
Publicado: (2020)

Molecular and hematologic relapses in adult patients with acute promyelocytic leukemia: a cohort study
por: Azevedo, Ilana de França, et al.
Publicado: (2017)

Complications during Induction Chemotherapy in Acute Promyelocytic Leukemia: An Institutional Experience
por: Yedla, Rajani Priya, et al.
Publicado: (2022)

Nonlymphoma hematological malignancies in systemic lupus erythematosus
por: Lu, M, et al.
Publicado: (2012)

Proceedings of the 2017 International Conference of Precision Health and Precision Nutrition: Shanghai, China. 6-7 November 2017
Publicado: (2018)

Acute Promyelocytic Leukemia
por: Thomas, Xavier, et al.
Publicado: (2020)

Comparison of annotation terms between automated and curated E. coli K12 databases
por: Marpuri, ReddySailaja, et al.
Publicado: (2009)

Linked annotations: a middle ground for manual curation of biomedical databases and text corpora
por: Goldberg, Tatyana, et al.
Publicado: (2015)

The 2nd International Conference on Agricultural and Biological Sciences (ABS 2016): Shanghai, China. 23-26 July 2016
por: Pei, Lei, et al.
Publicado: (2016)

APL programs for the mathematics classroom
por: Thomson, Norman D
Publicado: (1989)

Editorial: Welcome to APL Bioengineering
por: Cooper-White, Justin
Publicado: (2017)

Genomic amplification of MYC as double minutes in a patient with APL-like leukemia
por: Poddighe, Pino J, et al.
Publicado: (2014)

Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis
por: Guarnera, Luca, et al.
Publicado: (2022)

Institutional factors associated with early mortality of newly diagnosed acute promyelocytic leukemia
por: Matsuda, Kensuke, et al.
Publicado: (2022)

PW02-041 - Canakinumab treatment regimens in CAPS-patients
por: Hofer, F, et al.
Publicado: (2013)

Management of hematological patients in ICU: a retrospective study of 110 patients
por: Larché, J, et al.
Publicado: (2001)

Overcoming Gleevec-resistance by blocking oncogene addiction in malignant hematologic cells
por: Pan, Jingxuan
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_a56s8kv7pkq4in97kucj3c3rho